Astrana Health (ASTH) Operating Leases (2019 - 2026)

Astrana Health has disclosed Operating Leases across 8 years of filings, most recently posting $30.0 million for Q1 2026.

• Operating Leases for Q1 2026 came in at $30.0 million, up 3.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.0 million (up 3.6% YoY), and the FY2025 annual result was $31.6 million, up 2.93% from the prior year.
• Operating Leases came in at $30.0 million for Q1 2026 at Astrana Health, down from $31.6 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $42.7 million in Q1 2024 to a low of $15.2 million in Q1 2022.
• The 5-year median for Operating Leases is $28.7 million (2025), against an average of $26.8 million.
• Across the five-year window, Operating Leases surged 135.21% in 2024 and tumbled 32.21% in 2025, its largest moves.
• Astrana Health's Operating Leases stood at $19.9 million in 2022, then soared by 82.22% to $36.3 million in 2023, then decreased by 15.53% to $30.7 million in 2024, then grew by 2.93% to $31.6 million in 2025, then slipped by 4.9% to $30.0 million in 2026.
• The last three Operating Leases figures came in at $30.0 million (Q1 2026), $31.6 million (Q4 2025), and $30.2 million (Q3 2025), per Business Quant data.